Company Profile
Adicet Bio Stock Price, News & Analysis
- Ticker:
- ACET
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
7.93 USD (-13.43%)
Close
Last updated: August 6, 2026
75.8M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, ACET closed down 13.4% at $7.93. No new same-company headline was identified in the current news window.
Company overview
Business overview
Adicet Bio is a cell-therapy company focused on gamma delta T-cell therapies for cancer and immune disease. Its platform is trying to create off-the-shelf cell therapies with broader utility.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Adicet sits in advanced cell therapy.
Business Model Characteristics
The business depends on platform validation, manufacturing execution, and early clinical proof-of-concept.
Position Within the Biotechnology Landscape
Adicet is a high-catalyst cell-therapy name whose valuation is highly sensitive to translational progress.
Future catalysts
Adicet’s catalysts are ADI-001 and the rest of its allogeneic gamma delta CAR-T platform. The company needs clinical updates that keep the allogeneic story credible.
Recent news
- 01
- 02
Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock
Source: Adicet Bio
- 03
Adicet Bio, Inc. Announces Proposed Follow-On Offering of Common Stock
Source: Adicet Bio
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Adicet Bio (ACET)?
Adicet Bio (ACET) most recently closed at 7.93 USD, a -13.43% move versus the previous session.
What is the market cap of Adicet Bio (ACET)?
Adicet Bio currently has a market capitalization of 75.8M USD on BioPharmSignal.
What does Adicet Bio do?
Adicet Bio is a cell-therapy company focused on gamma delta T-cell therapies for cancer and immune disease. Its platform is trying to create off-the-shelf cell therapies with broader utility.
On which exchange is ACET stock listed?
Adicet Bio (ACET) is associated with NASDAQ, United States, Biopharma.
What is ADI-001?
Adicet’s catalysts are ADI-001 and the rest of its allogeneic gamma delta CAR-T platform.
Which conditions is Adicet Bio targeting with ADI-001?
Adicet Bio is associated with cancer therapeutics based on its company overview and current catalyst commentary.
How does Adicet Bio describe recent progress with ADI-001?
Adicet’s catalysts are ADI-001 and the rest of its allogeneic gamma delta CAR-T platform.
What is CAR-T?
Adicet’s catalysts are ADI-001 and the rest of its allogeneic gamma delta CAR-T platform.